Dna-sequncing-based


The Market For DNA-Sequncing-Based Down's Syndrome Tests Could Exceed $6 Billion

The Market For DNA-Sequncing-Based Down's Syndrome Tests Could Exceed $6 Billion

On Wednesday night the New England Journal of Medicine published a study showing that a new, DNA-sequencing based blood test pr...

Feb 28 2014, 12:26pm CST